4//SEC Filing
Bright Lisa 4
Accession 0001144204-18-063432
CIK 0001270073other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 7:00 PM ET
Size
10.1 KB
Accession
0001144204-18-063432
Insider Transaction Report
Form 4
Bright Lisa
CCO & Corp Affairs Officer
Transactions
- Sale
Common Stock
2018-12-03$111.23/sh−3,800$422,691→ 22,488 total - Sale
Common Stock
2018-12-03$112.12/sh−700$78,486→ 21,788 total - Sale
Common Stock
2018-12-04$111.00/sh−300$33,300→ 21,288 total - Sale
Common Stock
2018-12-03$113.22/sh−200$22,645→ 21,588 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.00 to $111.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.00 to $112.48, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.44, inclusive.
Documents
Issuer
INTERCEPT PHARMACEUTICALS, INC.
CIK 0001270073
Entity typeother
Related Parties
1- filerCIK 0001635111
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 7:00 PM ET
- Size
- 10.1 KB